Accéder au contenu
Merck

JMJD1B, a novel player in histone H3 and H4 processing to ensure genome stability.

Epigenetics & chromatin (2020-02-20)
Francisco Saavedra, Zachary A Gurard-Levin, Camila Rojas-Villalobos, Isabelle Vassias, Raquel Quatrini, Geneviève Almouzni, Alejandra Loyola
RÉSUMÉ

Maintaining a proper supply of soluble histones throughout the cell cycle is important to ensure chromatin and genome stability. Following their synthesis, histones undergo a series of maturation steps to prepare them for deposition onto chromatin. Here, we identify the lysine demethylase JMJD1B as a novel player in the maturation cascade that contributes to regulate histone provision. We find that depletion of JMJD1B increases the protein levels of the histone chaperone tNASP leading to an accumulation of newly synthesized histones H3 and H4 at early steps of the histone maturation cascade, which perturbs chromatin assembly. Furthermore, we find a high rate of JMJD1B mutations in cancer patients, and a correlation with genomic instability. Our data support a role for JMJD1B in fine-tuning histone supply to maintain genome integrity, opening novel avenues for cancer therapeutics.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal ANTI-FLAG® M2 antibody produced in mouse, clone M2, purified immunoglobulin (Purified IgG1 subclass), buffered aqueous solution (10 mM sodium phosphate, 150 mM NaCl, pH 7.4, containing 0.02% sodium azide)
Sigma-Aldrich
Anticorps monoclonal anti-β-actine antibody produced in mouse, clone AC-74, ascites fluid
Sigma-Aldrich
Anticorps anti-acétyl-histone H3, from rabbit
Sigma-Aldrich
Anti-acetyl-Histone H4 (Lys12) Antibody, serum, Upstate®
Sigma-Aldrich
MISSION® esiRNA, targeting human KDM3B
Sigma-Aldrich
MISSION® esiRNA, targeting human HIRA, C22ORF39
Sigma-Aldrich
MISSION® esiRNA, targeting human NASP